ArticleJournal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine2026
Validation of a deep learning-based system for sleep staging, arousal detection, and respiratory event scoring in atrial fibrillation patients.
Article in Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeObstructive sleep apnea is a common yet underdiagnosed sleep disorder in patients with atrial fibrillation (AF). Although polysomnography (PSG) is the gold standard, its costs and complexity limit routine use. Home sleep apnea testing (HSAT) is a more accessible alternative, but it lacks electroencephalography (EEG), limiting direct assessment of sleep stages and arousals. This study evaluates the performance of DeepRESP, an automated scoring solution that infers sleep stages and arousals using respiratory inductance plethysmography (RIP) signals and scoring respiratory events, in a cohort of patients with AF.
methodsIn this prospective cohort study, consecutive AF patients underwent ambulatory type II PSG. Automated respiratory event scoring, sleep staging and arousal identification were performed with DeepRESP using only HSAT signals. Performance metrics included epoch-level positive and negative percent agreement, complemented by concordance analyses for the apnea-hypopnea index (AHI), arousal index (ArI), and total sleep time (TST), using Bland-Altman analysis and intraclass correlation coefficients (ICC), with manually scored PSG as reference.
resultsA total of 88 patients (67.0% male) were included. Women were older than men (66.7 ± 7.2 vs. 61.27 ± 10.3 years, p = 0.015). Epoch-level overall percent agreement (OPA) with manual scoring was 0.91 for Wake, 0.95 for rapid eye movement sleep (REM), and 0.87 for non-rapid eye movement sleep (NREM). Arousal detection OPA was 0.80. Strong agreement was observed for the apnea-hypopnea index (ICC = 0.92), TST (ICC = 0.82), and ArI (ICC = 0.83).
conclusionIn AF patients, DeepRESP reliably estimates sleep architecture, arousals, and sleep apnea severity from HSAT signal, offering a scalable, EEG-independent diagnostic approach. CURRENT KNOWLEDGE/STUDY RATIONALE: Obstructive sleep apnea is highly prevalent and often underdiagnosed in atrial fibrillation patients, yet standard home testing lacks the neurophysiological channels necessary to detect arousals and accurate sleep architecture. This study was conducted to validate a deep learning-based system capable of inferring these critical metrics exclusively from home sleep testing signals, improving diagnostics performance within this specific cardiovascular population. STUDY IMPACT: The findings demonstrate that artificial intelligence-driven analysis of breathing patterns achieves high concordance with polysomnography for key diagnostic indices, including arousal index, total sleep time and apnea severity via the apnea-hypopnea index. This provides a scalable, precise diagnostic pathway that bypasses the confounding effects of arrhythmias and cardiac medications, facilitating improved management of sleep-disordered breathing in atrial fibrillation patients.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.